Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Featured News

Recent News

10/07/19GBT Announces New Employment Inducement Grants
10/02/19GBT Announces Upcoming Presentations at the 47th Annual National Sickle Cell Disease Association of America (SCDAA) Convention
10/01/19GBT to Host Analyst & Investor Day on October 8 in New York
09/25/19GBT Announces Participation at the 2019 Cantor Global Healthcare Conference

More »

Media Resources

Media Contact

Stephanie Yao